Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Revvity Omics, |
RCV003132872 | SCV003811499 | uncertain significance | not provided | 2020-04-05 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV003269548 | SCV003977389 | uncertain significance | Inborn genetic diseases | 2023-05-30 | criteria provided, single submitter | clinical testing | The c.11220G>T (p.K3740N) alteration is located in exon 77 (coding exon 75) of the NEB gene. This alteration results from a G to T substitution at nucleotide position 11220, causing the lysine (K) at amino acid position 3740 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Labcorp Genetics |
RCV003629245 | SCV004456679 | likely benign | Nemaline myopathy 2 | 2024-01-10 | criteria provided, single submitter | clinical testing |